Should I open or buy a Your CBD Store franchise in 2027?
Direct Answer
Proceed with real caution: Your CBD Store (SUNMED) is a CBD/hemp retail franchise in a category facing significant regulatory uncertainty and consolidation — validate the brand's current health and the regulatory environment carefully. Your CBD Store, founded in 2018, franchises CBD and hemp-wellness retail stores selling CBD oils, topicals, edibles, and wellness products under the SUNMED brand.
After explosive early growth, the CBD retail category has faced regulatory uncertainty (FDA, state rules, evolving hemp/Farm Bill policy), market saturation, and consolidation, and the brand has navigated franchisee-relations and growth challenges. The 2026 FDD points to a franchise fee around $5,000-$15,000, total investment of roughly $50,000 to $130,000 (very low), a low royalty, and a marketing fee.
Mature stores gross $200,000-$600,000, with owners clearing $40,000-$140,000. Its appeal is very low capital and the wellness/CBD interest; the major concerns are regulatory uncertainty, market saturation, and brand/category volatility — diligence is essential.
The Real Numbers
A Your CBD Store leases a small retail space (800-1,500 sq ft) selling CBD/hemp wellness products. The very low capital is appealing, but the CBD category's regulatory uncertainty and saturation are the dominant considerations.
| Line Item | Low | High | Notes |
|---|---|---|---|
| Franchise fee | $5,000 | $15,000 | Per 2026 FDD — low |
| Buildout / leasehold | $20,000 | $55,000 | Small retail fit-out |
| Equipment & fixtures | $8,000 | $25,000 | Shelving, POS |
| Signage & decor | $5,000 | $18,000 | Brand-prescribed |
| Initial inventory | $15,000 | $40,000 | CBD/hemp products |
| Initial marketing | $5,000 | $20,000 | Grand opening |
| Insurance & licensing | $3,000 | $12,000 | GL + state compliance |
| Working capital | $10,000 | $30,000 | First 3 months |
| Total investment | ~$50,000 | ~$130,000 | Per 2026 FDD — very low |
| Royalty | Low / per agreement | ||
| Marketing fee | ~2% of gross |
Revenue reality: mature stores gross $200K-$600K on CBD/hemp wellness retail, with owners clearing $40K-$140K. The very low capital is the main appeal. But the CBD category faces serious headwinds: regulatory uncertainty (FDA has not fully regulated CBD; state rules vary; hemp/Farm Bill policy is evolving), market saturation (CBD stores proliferated then consolidated), and price competition (online, big-box). The brand has also navigated franchisee-relations and growth challenges.
These category and brand risks outweigh the low capital unless rigorously validated. Diligence on regulatory exposure and current franchisee health is essential.
Who Wins With This Business
- Capital required: $50K-$130K, with $30,000-$70,000 liquid — very low.
- Time commitment: business-hours retail.
- Skills: retail operations, CBD/wellness knowledge, and regulatory compliance.
- Geographic fit: CBD-receptive, wellness-conscious markets.
- Lifestyle fit: hands-on, low-capital retail.
The winners are operators who rigorously validate the category/brand risk and manage regulatory compliance in receptive markets.
Who Loses With This Business
- Operators who ignore CBD regulatory uncertainty.
- Those in saturated or CBD-restrictive markets.
- Owners who can't differentiate against online/big-box CBD.
- Buyers who don't validate current brand/franchisee health.
- Those seduced by low capital without weighing category risk.
2027 Market Conditions
- Regulatory uncertainty: CBD/hemp regulation remains unsettled (FDA, state rules, evolving Farm Bill/hemp policy) — the dominant risk.
- Saturation/consolidation: CBD retail proliferated then consolidated — many stores closed.
- Competition: online, big-box, and pharmacies sell CBD — price pressure.
- Demand: CBD/wellness interest persists but is volatile and commoditizing.
- Brand volatility: validate the brand's current health given category challenges.
The 90-Day Decision Tree
- Day 1-20: Read the FDD AND research CBD/hemp regulatory status (FDA, state, Farm Bill) — the central risk.
- Day 21-45: Call 12+ current franchisees (more than usual) about regulatory issues, saturation, profitability, and brand support.
- Day 46-65: Validate the category and brand health — has the brand stabilized post-consolidation?
- Day 66-80: Assess your market's CBD receptivity and regulatory exposure.
- Day 81-90: Decide. If category/brand risk is high or unvalidated, choose a safer, more stable franchise.
- Proceed only if rigorously validated with a differentiation plan.
- Or pivot to a more stable wellness/retail category entirely.
Alternative Plays
- Established wellness franchises (Restore, iCRYO, The DRIPBaR) — more stable wellness.
- Nutrition retail (Nutrishop) — adjacent wellness retail (verify category).
- Pet/other low-capital retail — more stable low-capital options.
- Independent CBD store — full control, same category risk.
- Avoid regulatory-uncertain categories — a valid conclusion.
- Other low-capital franchises in stable categories — adjacent options.
FAQ
What is the biggest concern with Your CBD Store?
CBD/hemp regulatory uncertainty and category volatility. CBD remains incompletely regulated (FDA), with varying state rules and evolving hemp/Farm Bill policy, creating real regulatory risk. The category also proliferated then consolidated (many stores closed), and the brand has navigated challenges.
These risks outweigh the low capital unless rigorously validated. Diligence is essential.
How much does a Your CBD Store owner make?
Owners clear $40,000-$140,000 in stable stores, on $200K-$600K gross, with the very low capital improving return-on-investment. But category and regulatory risk make returns uncertain. Validate current franchisee profitability and brand health carefully — early CBD-boom economics may not reflect the current environment.
Is the CBD category still viable?
It's uncertain and consolidating. While CBD/wellness interest persists, the category faces regulatory uncertainty, saturation, commoditization, and price competition (online, big-box). Many CBD stores have closed. Viability depends heavily on regulatory developments, market receptivity, and differentiation.
It's a higher-risk category than stable franchises.
What should I validate before investing?
Regulatory status (FDA, state, Farm Bill), current franchisee profitability and turnover, brand health post-consolidation, and your market's CBD receptivity. Call 12+ current owners (more than usual), research the regulatory environment, and assess whether the brand has stabilized.
Given the risks, extra diligence is essential — or consider a safer category.
Should I choose a different franchise?
For many buyers, yes. Given CBD's regulatory uncertainty, saturation, and volatility, a more stable franchise (in a clearer regulatory and competitive environment) may offer better risk-adjusted returns. The low capital is appealing, but category risk is high. Only proceed if you've rigorously validated and have a strong differentiation/regulatory plan.
Bottom Line
Approach Your CBD Store with real caution — the CBD/hemp category faces significant regulatory uncertainty, saturation, and consolidation, and the brand has navigated challenges. Its very low capital is appealing, but category and regulatory risk are the dominant factors.
Validate exhaustively: research CBD regulation, call 12+ current owners, and confirm brand health — and be willing to walk away. For many buyers, a more stable franchise category offers better risk-adjusted returns. Only proceed if you've rigorously validated the regulatory environment, brand stability, and a differentiation plan in a CBD-receptive market.
This is a higher-risk, category-challenged opportunity.
Sources
- Your CBD Store / SUNMED Franchise Disclosure Document (2026 filing) — Items 3, 5, 6, 7, 19, 20
- Your CBD Store official franchise site — investment range and model
- Public reporting on CBD-retail consolidation and Your CBD Store challenges
- FDA and state CBD/hemp regulatory guidance, 2025-2026
- Farm Bill / hemp-policy developments, 2025-2026
- IBISWorld — CBD & Hemp Product Stores in the US, 2026 industry report
- Statista — US CBD market and regulatory-environment data, 2025-2026
- International Franchise Association (IFA) — 2027 Franchise Economic Outlook + due diligence
- Franchise Business Review — retail-franchise satisfaction data
- Brightfield Group / CBD-market consolidation data 2026